Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Maxim Grymonprez

Awards & Distinctions

33 Results

2025

Minimal adherence threshold to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation to reduce the risk of thromboembolism and death : a nationwide cohort study

Maxim GrymonprezStephane SteurbautAndreas CapiauDelphine VauterinFrauke Van VaerenberghEls MehuysKoen BousseryTine De BackerLies Lahousse

A1 Journal Article in CARDIOVASCULAR DRUGS AND THERAPY

Pharmacodynamic drug-drug interactions and bleeding outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study

Maxim GrymonprezAndreas CapiauStephane SteurbautKoen BousseryEls MehuysAnnemie SomersMirko PetrovicTine De BackerLies Lahousse

A1 Journal Article in CARDIOVASCULAR DRUGS AND THERAPY

Predictors of mortality and hospitalised exacerbations in obstructive airway diseases

Delphine VauterinFrauke Van VaerenberghMaxim GrymonprezGuy JoosLies Lahousse

A1 Journal Article in ERJ OPEN RESEARCH

2024

Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants : an intervention study in community pharmacies

Andreas CapiauEls MehuysMaxim GrymonprezInge Van TongelenThierry ChristiaensEline TommeleinGeneviève PhilippeLies LahousseTine De BackerKoen Boussery

A1 Journal Article in THROMBOSIS RESEARCH

Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation : a nationwide cohort study

Maxim GrymonprezMirko PetrovicTine De BackerStephane SteurbautLies Lahousse

A1 Journal Article in EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES

Medication adherence to inhalation therapy and the risk of COPD exacerbations : a systematic review with meta-analysis

Delphine VauterinFrauke Van VaerenberghMaxim GrymonprezAnna VanoverscheldeLies Lahousse

A1 Journal Article in BMJ OPEN RESPIRATORY RESEARCH

Potentially inappropriate prescribing in multimorbid and polymedicated older adults with AF : a systematic review and meta-analysis

Cheïma AmrouchDelphine VauterinSouad AmrouchMaxim GrymonprezLu DaiCecilia DamianoAmaia Calderón-LarrañagaLies LahousseDirk De BacquerGregory Y. H. Lip et al.

A1 Journal Article in DRUGS & AGING

Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity : a Swedish national register-based cohort study

Cheïma AmrouchDavide Liborio VetranoCecilia DamianoLu DaiAmaia Calderón-LarrañagaMaxim GrymonprezMarco ProiettiGregory LipSøren JohnsenJonas Wastesson et al.

A1 Journal Article in FRONTIERS IN PHARMACOLOGY

The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Maxim GrymonprezMirko PetrovicTine De BackerStephane SteurbautLies Lahousse

A1 Journal Article in THROMBOSIS AND HAEMOSTASIS

2023

Barriers and facilitators for adherence to direct oral anticoagulants in patients with atrial fibrillation : a qualitative approach

Andreas CapiauMaxim GrymonprezSophie ScheireYenna FauteLies LahousseEls MehuysTine De BackerKoen Boussery

A1 Journal Article in THROMBOSIS RESEARCH

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study

Maxim GrymonprezMirko PetrovicTine De BackerStephane SteurbautLies Lahousse

A2 Journal Article in IJC HEART & VASCULATURE

Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists : a Belgian nationwide cohort study

Maxim GrymonprezMirko PetrovicTine De BackerM Arfan IkramStephane SteurbautLies Lahousse

A1 Journal Article in AGE AND AGEING

Factors influencing the choice of and adherence to oral anticoagulants in patients with atrial fibrillation: a Belgian nationwide cohort study

Maxim GrymonprezTine De BackerAndreas CapiauDelphine VauterinEls MehuysKoen BousseryStephane SteurbautLies Lahousse

Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study

Maxim GrymonprezLaura CarnoyAndreas CapiauKoen BousseryEls MehuysTine L. De BackerStephane SteurbautLies Lahousse

A1 Journal Article in EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation : a nationwide cohort study

Maxim GrymonprezTine De BackerXander BertelsStephane SteurbautLies Lahousse

A1 Journal Article in FRONTIERS IN PHARMACOLOGY

Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation using P-gp and/or CYP450-interacting drugs : a systematic review and meta-analysis

Maxim GrymonprezKevin VansprangheStephane SteurbautTine De BackerLies Lahousse

A1 Journal Article in CARDIOVASCULAR DRUGS AND THERAPY

Optimal adherence threshold to non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation to reduce the risk of thromboembolism and death

Maxim GrymonprezS. SteurbautAndreas CapiauDelphine VauterinFrauke Van VaerenberghEls MehuysKoen BousseryTine De BackerLies Lahousse

Rational oral anticoagulant use in patients with atrial fibrillation

Maxim GrymonprezLies LahousseStephane Steurbout

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019 : a nationwide cohort study

Maxim GrymonprezTine De BackerAndreas CapiauDelphine VauterinEls MehuysKoen BousseryStephane SteurbautLies Lahousse

A1 Journal Article in BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

2022

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation : a Belgian nationwide cohort study

Maxim GrymonprezAndreas CapiauStephane SteurbautEls MehuysKoen BousseryTine De BackerLies Lahousse

A1 Journal Article in FRONTIERS IN CARDIOVASCULAR MEDICINE

Effectiviteit en veiligheid van directe orale anticoagulantia bij patiënten met voorkamerfibrillatie

Andreas CapiauMaxim GrymonprezKoen BousseryLies LahousseTine De Backer

A2 Journal Article in TIJDSCHRIFT VOOR CARDIOLOGIE

Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation : a meta-analysis

Maxim GrymonprezKevin VansprangheAndreas CapiauKoen BousseryStephane SteurbautLies Lahousse

A1 Journal Article in BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation and (morbid) obesity or low body weight : a systematic review and meta-analysis

Maxim GrymonprezTine De BackerStephane SteurbautKoen BousseryLies Lahousse

A1 Journal Article in CARDIOVASCULAR DRUGS AND THERAPY

Risico-batenprofiel van een standaard en een lagere dosis directe orale anticoagulantia versus warfarine bij patiënten met voorkamerfibrillatie

Maxim GrymonprezAndreas Capiau

A2 Journal Article in MINERVA

Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018 : a systematic review and meta-analysis

Maxim GrymonprezCynthia SimoensStephane SteurbautTine De BackerLies Lahousse

A1 Journal Article in EUROPACE

2021

Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA Practical Guide

Andreas CapiauTine De BackerMaxim GrymonprezLies LahousseInge Van TongelenEls MehuysKoen Boussery

A1 Journal Article in INTERNATIONAL JOURNAL OF CARDIOLOGY

Comparison of cerebral blood flow in subjects with and without chronic obstructive pulmonary disease from the population-based Rotterdam Study

Sara WijnantDaniel BosGuy BrusselleMaxim GrymonprezErnst RietzschelMeike W. VernooijNatalie TerzikhanLies Lahousse

A1 Journal Article in BMJ OPEN

Niet-vitamine K-antagonist orale anticoagulantia bij oudere patiënten met voorkamerfibrillatie

Maxim GrymonprezStephane SteurbautTine De BackerMirko PetrovicLies Lahousse

A2 Journal Article in TIJDSCHRIFT VOOR CARDIOLOGIE

The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation : a systematic review and meta‐analysis on the obesity paradox

Maxim GrymonprezAndreas CapiauTine De BackerStephane SteurbautKoen BousseryLies Lahousse

A1 Journal Article in CLINICAL CARDIOLOGY

Voorkamerfibrillatie en niet-vitamine K-antagonist orale anticoagulantia : van klinische studies tot gebruik in de dagelijkse praktijk

Andreas CapiauMaxim GrymonprezTine De BackerSofie GevaertKoen BousseryLies Lahousse

A2 Journal Article in TIJDSCHRIFT VOOR GENEESKUNDE

2020

Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation : a systematic review and meta-analysis

Maxim GrymonprezStephane SteurbautTine De BackerMirko PetrovicLies Lahousse

A1 Journal Article in FRONTIERS IN PHARMACOLOGY

Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes : a systematic review and meta-analysis

Maxim GrymonprezStephane SteurbautAn De SutterLies Lahousse

A2 Journal Article in OPEN HEART

2019

Chronic obstructive pulmonary disease and the development of atrial fibrillation

Maxim GrymonprezVincent VakaetMaryam KavousiBruno H StrickerM Arfan IkramJan HeeringaOscar H FrancoGuy BrusselleLies Lahousse

A1 Journal Article in INTERNATIONAL JOURNAL OF CARDIOLOGY